Rakovina Therapeutics appoints Yale Brain Tumor Center scientific director Ranjit Bindra to advisory board

• Rakovina Therapeutics named Dr. Ranjit Bindra to its Scientific Advisory Board.
• Bindra serves as scientific director of the Yale Brain Tumor Center.
• He is the Harvey and Kate Cushing Professor of Therapeutic Radiology at Yale School of Medicine.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rakovina Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609170430PRIMZONEFULLFEED9828604) on September 17, 2026, and is solely responsible for the information contained therein.